You just read:

John Theurer Cancer Center Leading Enrollment for Global Phase 2 WIZARD Study Evaluating DSP-7888 in Patients with Recurrent Glioblastoma

News provided by

John Theurer Cancer Center

Jan 29, 2019, 12:52 ET